It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 1971.
1971 | Indore, Madhya Pradesh, India | ActivePromed Laboratories Private Limited, a active private limited company, was established on 24 July 1971 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85195MP1971PTC001100. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.68 Cr.
It upholds a compliant status. Employing 3 professional, Its leadership includes Subhash Rijhwani (Director), Mahesh Badlani (Director), Pankaj Badlani (Director). Past directors included Jairamdas Badlani. It holds ₹1.50 M open charges and ₹17.96 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at G-3A Shreenath Nitetan,, 29, Snehlata Ganj, Indore, Madhya Pradesh, 452003.
U85195MP1971PTC001100
001100
24 July 1971
₹2.00 Cr
₹1.68 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Promed Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subhash Rijhwani | Director | 02 Mar 1994 | Current |
| Mahesh Badlani | Director | 02 Mar 1994 | Current |
| Pankaj Badlani | Director | 01 Sep 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Promed Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.99% decrease. The company also saw a substantial fall in profitability, with a 1330.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Promed Laboratories had a public holding of 28.98%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,500,000.00
₹179,605,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2025 | Hdfc Bank Limited | ₹1.50 M | Open |
| 09 Sep 2016 | Others | ₹3.75 Cr | Satisfied |
| 06 Sep 2005 | Bank Of Baroda | ₹8.30 Cr | Satisfied |
| 28 Jul 2005 | Bank Of Baroda | ₹5.91 Cr | Satisfied |
Explore comprehensive loan charge details -
Promed Laboratories has a workforce of 3 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Promed Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Promed Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 101088171 was registered on 11 Mar 2025. was recorded as a recent event.
The activity Promed Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Promed Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
A charge registered on 09 Sep 2016 via Charge ID 100058369 with Others was fully satisfied on 13 Oct 2023. was recorded as a recent event.
A charge registered on 06 Sep 2005 via Charge ID 80048723 with Bank Of Baroda was fully satisfied on 27 Sep 2023. was recorded as a recent event.
A charge registered on 28 Jul 2005 via Charge ID 80048721 with Bank Of Baroda was fully satisfied on 27 Sep 2023. was recorded as a recent event.
The CIN of Promed Laboratories Private Limited is U85195MP1971PTC001100.
Promed Laboratories Private Limited is headquartered at G-3A Shreenath Nitetan,, 29, Snehlata Ganj, Indore, Madhya Pradesh, 452003.
Promed Laboratories Private Limited was incorporated on 24 July 1971.
The current directors of Promed Laboratories Private Limited are
The primary industry of Promed Laboratories Private Limited is Manufacturing.
Promed Laboratories Private Limited is unlisted.
The authorized capital of Promed Laboratories Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.68 Cr.
The compliance status of Promed Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX